z-logo
open-access-imgOpen Access
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
Author(s) -
Qinheng Zheng,
Jordan L. Woehl,
Seiya Kitamura,
Diogo SantosMartins,
Christopher J. Smedley,
Gencheng Li,
Stefano Forli,
John E. Moses,
Dennis W. Wolan,
K. Barry Sharpless
Publication year - 2019
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1909972116
Subject(s) - chemistry , derivatization , covalent bond , serine , elastase , serine protease , biochemistry , combinatorial chemistry , neutrophil elastase , proteases , protease , enzyme , organic chemistry , biology , inflammation , immunology , high performance liquid chromatography
Significance An agnostic screen of our collection of stable sulfur fluoride exchange (SuFEx)able derivatives discovers a promising class of covalent and highly selective, elastase inhibitors. Their dormant behavior is a reflection of an exquisite sensitivity in choice of a protein reaction partner, like a “sleeping beauty finding the right prince.” Hence a special SuFEx catalysis environment is required for the perfect matchmaking event: a naturally folded protein with precise electrostatic and geometric setups, such that one of its own nucleophilic side chain ends up replacing the probe’s S–F link to become permanently covalent. In contrast, the same protein, when denatured, is incapable of being covalently modified by the same probe.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom